<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2022.1013294</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Relative bradycardia presented as a clinical feature of <italic>Brucella melitensis</italic> infection: A case report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Huang</surname> <given-names>Kai</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/1948313/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yu</surname> <given-names>Xuxia</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Yu</surname> <given-names>Yushan</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Cen</surname> <given-names>Yin</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Shu</surname> <given-names>Jie</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/1850946/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yang</surname> <given-names>Naibin</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1225775/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Chu</surname> <given-names>Jinguo</given-names></name>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1286792/overview"/>
</contrib>
</contrib-group>
<aff><institution>Ningbo First Hospital</institution>, <addr-line>Ningbo</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Francesco Paolo Bianchi, University of Bari Aldo Moro, Italy</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Maryam Dadar, Razi Vaccine and Serum Research Institute, Iran; Steven Olsen, Agricultural Research Service (USDA), United States</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Naibin Yang <email>yangnb01&#x00040;163.com</email></corresp>
<corresp id="c002">Jinguo Chu <email>chujg&#x00040;126.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Infectious Diseases: Pathogenesis and Therapy, a section of the journal Frontiers in Medicine</p></fn></author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>12</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>9</volume>
<elocation-id>1013294</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>08</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>11</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Huang, Yu, Yu, Cen, Shu, Yang and Chu.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Huang, Yu, Yu, Cen, Shu, Yang and Chu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> </permissions>
<abstract>
<p>Brucellosis, caused by <italic>Brucella</italic> species, is an infectious disease transmitted through contact with infected animals or their secretions. The clinical disease is characterized by fever and headache. Relative bradycardia is an inappropriate response of heart rate to body temperature, in which the heart rate does not increase proportionally despite a high fever. In this report, we document one case of <italic>Brucella melitensis</italic> infection demonstrating relative bradycardia. To our knowledge, this is the first report of relative bradycardia in a patient with brucellosis.</p></abstract>
<kwd-group>
<kwd>brucellosis</kwd>
<kwd><italic>Brucella melitensis</italic></kwd>
<kwd>relative bradycardia</kwd>
<kwd>clinical feature</kwd>
<kwd>heart rate and body temperature relationship</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="16"/>
<page-count count="5"/>
<word-count count="2382"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Brucellosis is a zoonotic disease that causes more than 500,000 new infections per year across the world. The disease is usually transmitted from animals to humans through contact with infected animals or by consuming contaminated animal products. Common symptoms of brucellosis include headache, fever, fatigue, sweating, joint pain, and weakness (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Brucellosis is still very common and often considered a neglected disease (<xref ref-type="bibr" rid="B3">3</xref>). Relative bradycardia is an important diagnostic clue in a variety of infectious and non-infectious diseases (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). Previous studies found that relative bradycardia was not associated with brucellosis (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). In this study, we report a case of <italic>Brucella melitensis</italic> infection exhibiting relative bradycardia. To the best of our knowledge, no similar cases have previously been reported in the literature.</p>
</sec>
<sec id="s2">
<title>Case presentation</title>
<p>On 24 May 2021, a 51-year-old woman was admitted to our hospital with a 1-week history of fever. She developed a fever of 39.5&#x000B0;C with chills that lasted for about 20&#x02013;30 min as well as cough, headaches, sweating, and fatigue. The patient was evaluated in an emergency department 5 days previous to the presentation. On examination, blood analysis demonstrated normal white blood cell counts (4.25 &#x000D7; 10<sup>9</sup>/L) and neutrophil percentage (63.7%), and elevated C-reactive protein (CRP, 8.66 mg/L) with chest computed tomography (CT) within normal limits. The patient was treated with ceftriaxone (2g qd ivgtt) for 2 days but body temperatures remained elevated (&#x0003E;39&#x02013;40&#x000B0;C) and other clinical symptoms also persisted. The patient was admitted for hospitalization.</p>
<p>The patient&#x00027;s history indicated that she was a farmer and worked with sheep. The patient reported no previous history of symptoms and was not on medication that could cause symptoms. Other family members did not report similar symptoms. Physical examination was within normal limits. Laboratory results indicated significant elevations of CRP and serum amyloid protein A (SAA) and moderate to minor elevations of D-dimer, alanine aminotransferase, aspartate aminotransferase, adenosine deaminase, creatinine, procalcitonin (PCT), and hepatitis B surface antibody (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Laboratory examination results of the case at admission.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Items</bold></th>
<th valign="top" align="center"><bold>Values</bold></th>
<th valign="top" align="center"><bold>Reference range</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">White blood cell count ( &#x000D7; 10<sup>9</sup> /L)</td>
<td valign="top" align="center">3.62</td>
<td valign="top" align="center">3.50&#x02013;9.50</td>
</tr>
<tr>
<td valign="top" align="left">Neutrophil count ( &#x000D7; 10<sup>9</sup> /L)</td>
<td valign="top" align="center">2.4</td>
<td valign="top" align="center">1.8&#x02013;6.3</td>
</tr>
<tr>
<td valign="top" align="left">Lymphocyte count ( &#x000D7; 10<sup>9</sup> /L)</td>
<td valign="top" align="center">0.9</td>
<td valign="top" align="center">1.1&#x02013;3.2</td>
</tr>
<tr>
<td valign="top" align="left">Monocyte count ( &#x000D7; 10<sup>9</sup> /L)</td>
<td valign="top" align="center">0.4</td>
<td valign="top" align="center">0.1&#x02013;0.6</td>
</tr>
<tr>
<td valign="top" align="left">Red blood cell count ( &#x000D7; 10<sup>12</sup> /L)</td>
<td valign="top" align="center">4.32</td>
<td valign="top" align="center">3.8&#x02013;5.1</td>
</tr>
<tr>
<td valign="top" align="left">Hemoglobin (g/L)</td>
<td valign="top" align="center">115</td>
<td valign="top" align="center">115.0&#x02013;150.0</td>
</tr>
<tr>
<td valign="top" align="left">Platelet count ( &#x000D7; 10<sup>9</sup> /L)</td>
<td valign="top" align="center">134</td>
<td valign="top" align="center">125.0&#x02013;350.0</td>
</tr>
<tr>
<td valign="top" align="left">High sensitivity C-reactive protein(mg/l)</td>
<td valign="top" align="center">48.13</td>
<td valign="top" align="center">0&#x02013;5.0</td>
</tr>
<tr>
<td valign="top" align="left">D-dimer(ng/ml)</td>
<td valign="top" align="center">1,406</td>
<td valign="top" align="center">0&#x02013;243</td>
</tr>
<tr>
<td valign="top" align="left">Erythrocyte sedimentation rate (mm/h)</td>
<td valign="top" align="center">29</td>
<td valign="top" align="center">&#x0003C; 38</td>
</tr>
<tr>
<td valign="top" align="left">Glycated-hemoglobin(%)</td>
<td valign="top" align="center">5.8</td>
<td valign="top" align="center">4.0&#x02013;6.0</td>
</tr>
<tr>
<td valign="top" align="left">Alanine aminotransferase (U/L)</td>
<td valign="top" align="center">42</td>
<td valign="top" align="center">7&#x02013;40</td>
</tr>
<tr>
<td valign="top" align="left">Aspartate aminotransferase (U/L)</td>
<td valign="top" align="center">55</td>
<td valign="top" align="center">13&#x02013;35</td>
</tr>
<tr>
<td valign="top" align="left">&#x003B3;-Glutamyl transpeptidase (U/L)</td>
<td valign="top" align="center">27</td>
<td valign="top" align="center">7&#x02013;45</td>
</tr>
<tr>
<td valign="top" align="left">Alkaline phosphatase (U/L)</td>
<td valign="top" align="center">80</td>
<td valign="top" align="center">50&#x02013;135</td>
</tr>
<tr>
<td valign="top" align="left">Total bilirubin (&#x003BC;mol/L)</td>
<td valign="top" align="center">4.4</td>
<td valign="top" align="center">3.4&#x02013;20.5</td>
</tr>
<tr>
<td valign="top" align="left">Direct bilirubin (&#x003BC;mol/L)</td>
<td valign="top" align="center">2.1</td>
<td valign="top" align="center">0.0&#x02013;6.84</td>
</tr>
<tr>
<td valign="top" align="left">Indirect bilirubin (&#x003BC;mol/L)</td>
<td valign="top" align="center">2.3</td>
<td valign="top" align="center">1.7&#x02013;13.7</td>
</tr>
<tr>
<td valign="top" align="left">Adenosine deaminase (U/L)</td>
<td valign="top" align="center">42.3</td>
<td valign="top" align="center">4.0&#x02013;22.0</td>
</tr>
<tr>
<td valign="top" align="left">Urea nitrogen (mmol/l)</td>
<td valign="top" align="center">4.4</td>
<td valign="top" align="center">2.6&#x02013;7.5</td>
</tr>
<tr>
<td valign="top" align="left">Creatinine (umol/l)</td>
<td valign="top" align="center">74</td>
<td valign="top" align="center">41&#x02013;73</td>
</tr>
<tr>
<td valign="top" align="left">Creatine kinase isoenzyme (ng/ml)</td>
<td valign="top" align="center">1.54</td>
<td valign="top" align="center">0&#x02013;5.0</td>
</tr>
<tr>
<td valign="top" align="left">Procalcitonin(ng/ml)</td>
<td valign="top" align="center">0.37</td>
<td valign="top" align="center">0&#x02013;0.05</td>
</tr>
<tr>
<td valign="top" align="left">Serum Amyloid Protein A(mg/l)</td>
<td valign="top" align="center">368.7</td>
<td valign="top" align="center">0&#x02013;10.0</td>
</tr>
<tr>
<td valign="top" align="left">EBVDNA</td>
<td valign="top" align="center">&#x0003C; 5.0 &#x000D7; 10<sup>3</sup></td>
<td valign="top" align="center">&#x0003C; 5.0 &#x000D7; 10<sup>3</sup></td>
</tr>
<tr>
<td valign="top" align="left">CMVDNA</td>
<td valign="top" align="center">&#x0003C; 2.0 &#x000D7; 10<sup>3</sup></td>
<td valign="top" align="center">&#x0003C; 2.0 &#x000D7; 10<sup>3</sup></td>
</tr>
<tr>
<td valign="top" align="left">Blood plasmodium</td>
<td valign="top" align="center">Negative</td>
<td valign="top" align="center">Negative</td>
</tr>
<tr>
<td valign="top" align="left">Widal test</td>
<td valign="top" align="center">Negative</td>
<td valign="top" align="center">Negative</td>
</tr>
<tr>
<td valign="top" align="left">Hepatitis B surface antigen (IU/ml)</td>
<td valign="top" align="center">0.01</td>
<td valign="top" align="center">0.00&#x02013;0.05</td>
</tr>
<tr>
<td valign="top" align="left">Hepatitis B surface antibody (mIU/ml)</td>
<td valign="top" align="center">18.46</td>
<td valign="top" align="center">0.00&#x02013;10.00</td>
</tr>
<tr>
<td valign="top" align="left">Hepatitis C virus antibody</td>
<td valign="top" align="center">Negative</td>
<td valign="top" align="center">Negative</td>
</tr>
<tr>
<td valign="top" align="left">Human immunodeficiency virus antibody</td>
<td valign="top" align="center">Negative</td>
<td valign="top" align="center">Negative</td>
</tr>
<tr>
<td valign="top" align="left">Treponema pallidum antibody</td>
<td valign="top" align="center">Negative</td>
<td valign="top" align="center">Negative</td>
</tr>
<tr>
<td valign="top" align="left">Blood culture</td>
<td valign="top" align="center"><italic>Brucella melitensis</italic></td>
<td valign="top" align="center">Negative</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>At admission, electrocardiograms (ECGs) showed a heart rate (HR) of only 74 beats per minute (bpm) with sinus rhythm despite a body temperature of 39.1&#x000B0;C. The ECG demonstrated no arrhythmia, shortening of the PR segment, ST elevation or depression, conduction block, or T wave changes (<xref ref-type="fig" rid="F1">Figure 1</xref>). Throughout the clinical course, the echocardiogram demonstrated normal left ventricular function and intracardiac structure, without asynergy. While hospitalization with a high fever sometimes exceeded 40&#x000B0;C, the HR remained between 70 and 100 bpm with a sinus rhythm (<xref ref-type="fig" rid="F2">Figure 2</xref>). The patient was not receiving beta-blocker therapy. In accordance with Cunha&#x00027;s criteria (<xref ref-type="bibr" rid="B5">5</xref>), the patient was diagnosed with relative bradycardia.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Electrocardiograms at admission (electrocardiograms showed a heart rate of only 74 beats per minute with sinus rhythm despite a body temperature of 39.1&#x000B0;C, without arrhythmia, no shortening of the PR segment, ST elevation or depression, and conduction block or T wave change).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-09-1013294-g0001.tif"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>The time course of heart rate, fever, and treatment in the case (during the first week of hospitalization, persistently high fever with highest temperature &#x0003E;40&#x000B0;C, the HR remained within 70&#x02013;100 bpm with sinus rhythm. bpm, beats per minute; BT, body temperature; HR, heart rate; DMX, dexamethasone).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-09-1013294-g0002.tif"/>
</fig>
<p>On day 6, blood culture was positive for the recovery of <italic>B. melitensis</italic> identified by mass spectrometry (MALDI-TOF MS), and the patient was diagnosed with brucellosis. The patient resided in a part of China (Zhejiang Province) that is not considered endemic for brucellosis.</p>
<p>After being diagnosed with brucellosis, the patient was treated with rifampicin (450 mg qd po) and doxycycline (100 mg bid po) for 6 weeks in accordance with Chinese guidelines (<xref ref-type="bibr" rid="B6">6</xref>). The patient responded to antibiotic treatment without any adverse clinical effects. After treatment, the patient&#x00027;s body temperature returned to normal limits on day 9 and she was discharged from the hospital in stable condition on day 13. At the latest follow-up 3 months after discharge, the patient did not report any symptoms. The whole process was concluded (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Timeline of the case.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-09-1013294-g0003.tif"/>
</fig>
</sec>
<sec sec-type="discussion" id="s3">
<title>Discussion</title>
<p><italic>Brucella melitensis</italic> is the most virulent and the most prevalent worldwide among <italic>Brucella</italic> species. The hosts of <italic>B. melitensis</italic> are sheep and goats. <italic>B. melitensis</italic> is commonly infected by exposure to animals or animal products (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). The incubation period is usually between 5 and 60 days (<xref ref-type="bibr" rid="B7">7</xref>). Based on clinical symptoms, epidemiological history, and positive blood culture, our case was diagnosed with brucellosis. The indications of occupational exposure had regulatory importance as the patient was from an area considered to be non-endemic for brucellosis. In the current case of <italic>B. melitensis</italic> infection, we observed elevated inflammatory biomarkers (CRP, PCT, and SAA) and also noted indications of damage to liver function consistent with other reports (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>Cardiac involvement (such as endocarditis, myocarditis, and pericarditis) occurs in &#x0003C; 2% of patients with brucellosis, but in endemic regions, this rate can increase between 7 and 10% and is the most common cause of death (<xref ref-type="bibr" rid="B10">10</xref>). The most common and most important complication is endocarditis (<xref ref-type="bibr" rid="B11">11</xref>). <italic>Brucella</italic> endocarditis has a predominance of aortic involvement and is prone to left ventricular failure (<xref ref-type="bibr" rid="B12">12</xref>). Cetin M et al. demonstrated that the parameters of ECG including Pmax, Pdis, QTmax, QTdis, QTcdis, Tp-edis interval, Tp-emax/QTmax, and Tp-emax/QTcmax ratios were significantly longer among children with brucellosis compared with healthy children, which indicates that the cardiac conduction pathways are affected (<xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>Relative bradycardia is a clinical phenomenon demonstrating an insufficient increase in the heart rate despite the high fever, which may occur in some infectious diseases (including COVID-19) (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). Bradycardia occurrence may correlate with the severity of the disease, as these cases were more likely to develop relative bradycardia (<xref ref-type="bibr" rid="B14">14</xref>), and HR tends to be lower, sometimes &#x0003C; 60 bpm among patients with COVID-19 (<xref ref-type="bibr" rid="B15">15</xref>). In the current case, HR varied from 60 to 100 bpm, and there was no evidence that relative bradycardia was associated with the severity of brucellosis.</p>
<p>Although mechanisms causing relative bradycardia remain unknown, inflammatory cytokines (such as interleukin 6), direct pathogenic effects on the heart (such as the sinoatrial node), increased vagal tone, and/or induction of electrolyte abnormalities have been proposed (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B16">16</xref>). In the current case, cardiac biomarkers, ECG, and echocardiogram were all within normal limits and no evidence of myocardial damage was detected. The elevations in CRP, PCT and SAA suggest a role for inflammation. We considered that relative bradycardia of <italic>B. melitensis</italic> infection might be caused by inflammatory cytokines.</p>
<p>We have described and considered the potential mechanisms of a case of brucellosis with relative bradycardia. Relative bradycardia could be used as a clinical tool for the diagnosis of various disease etiologies, especially infectious diseases (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Our case demonstrates that relative bradycardia could be associated with <italic>B. melitensis</italic> infection, an observation that has not been previously reported. Clinicians should consider brucellosis in patients with high fever exhibiting relative bradycardia.</p>
<p>Some limitations were discovered in this case study. First, IL-6 was not measured, so the relation between IL-6 and relative bradycardia is not evaluated. Second, because the follow-up time was short, the long-term effect of the treatment of rifampicin and doxycycline should be assessed in future studies.</p>
</sec>
<sec sec-type="data-availability" id="s4">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.</p>
</sec>
<sec sec-type="ethics-statement" id="s5">
<title>Ethics statement</title>
<p>The study involving human participant was reviewed and approved by the Medical Ethical Committees of Ningbo First Hospital (approval number: 2022RS125). Written informed consent from the [patients/ participants OR patients/participants legal guardian/next of kin] was not required to participate in this study in accordance with the national legislation and the institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="s6">
<title>Author contributions</title>
<p>KH and XY analyzed and interpreted the clinical data. KH, XY, YY, YC, and JS drafted the manuscript. NY and JC revised the manuscript. All authors have read and approved the manuscript.</p>
</sec>
</body>
<back>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s7">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Hayoun</surname> <given-names>MA</given-names></name> <name><surname>Muco</surname> <given-names>E</given-names></name> <name><surname>Shorman</surname> <given-names>M</given-names></name></person-group>. <article-title>Brucellosis</article-title>. In: <source>StatPearls</source>. (<year>2022</year>). <publisher-loc>Treasure Island (FL)</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK441831/">https://www.ncbi.nlm.nih.gov/books/NBK441831/</ext-link> (accessed on May 9, 2022).</citation>
</ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Duan</surname> <given-names>K</given-names></name> <name><surname>Peng</surname> <given-names>Q</given-names></name></person-group>. <article-title>Research progress on brucellosis</article-title>. <source>Curr Med Chem.</source> (<year>2019</year>) <volume>26</volume>:<fpage>5598</fpage>&#x02013;<lpage>608</lpage>. <pub-id pub-id-type="doi">10.2174/0929867325666180510125009</pub-id><pub-id pub-id-type="pmid">29745323</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname> <given-names>MP</given-names></name> <name><surname>Mulder</surname> <given-names>M</given-names></name> <name><surname>Gilman</surname> <given-names>RH</given-names></name> <name><surname>Smits</surname> <given-names>HL</given-names></name></person-group>. <article-title>Human brucellosis</article-title>. <source>Lancet Infect Dis.</source> (<year>2007</year>) <volume>7</volume>:<fpage>775</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(07)70286-4</pub-id><pub-id pub-id-type="pmid">18045560</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>F</given-names></name> <name><surname>Hatahet</surname> <given-names>M</given-names></name> <name><surname>Youniss</surname> <given-names>MA</given-names></name> <name><surname>Toklu</surname> <given-names>HZ</given-names></name> <name><surname>Mazza</surname> <given-names>JJ</given-names></name> <name><surname>Yale</surname> <given-names>S</given-names></name></person-group>. <article-title>The clinical significance of relative bradycardia</article-title>. <source>WMJ</source>.<year>2018</year>; <volume>117</volume>:<fpage>73</fpage>&#x02013;<lpage>78</lpage>.</citation>
</ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cunha</surname> <given-names>BA</given-names></name></person-group>. <article-title>The diagnostic significance of relative bradycardia in infectious disease</article-title>. <source>Clin Microbiol Infect.</source> (<year>2000</year>) <volume>6</volume>:<fpage>633</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1046/j.1469-0691.2000.0194f.x</pub-id><pub-id pub-id-type="pmid">11284920</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><collab>National Health Commission of the People&#x00027;s Republic of China</collab></person-group>. <source>Guidelines for diagnosis and treatment of brucellosis</source>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=56110">http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=56110</ext-link> (accessed on October 22, 2012; June 8, 2022).</citation>
</ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marr</surname> <given-names>JS</given-names></name> <name><surname>Cathey</surname> <given-names>JT</given-names></name></person-group>. <article-title>A Century in the Life of the Control of Communicable Diseases Manual: 1917 to 2017</article-title>. <source>J Public Health Manag Pract</source>. (<year>2016</year>) <volume>22</volume>:<fpage>597</fpage>&#x02013;<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1097/PHH.0000000000000435</pub-id><pub-id pub-id-type="pmid">27682728</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name> <name><surname>Zhao</surname> <given-names>X</given-names></name></person-group>. <article-title>Clinical features and serum profile of inflammatory biomarkers in patients with brucellosis</article-title>. <source>J Infect Dev Ctries.</source> (<year>2017</year>) <volume>11</volume>:<fpage>840</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3855/jidc.8872</pub-id><pub-id pub-id-type="pmid">31618182</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okan</surname> <given-names>DH</given-names></name> <name><surname>G&#x000F6;kmen</surname> <given-names>Z</given-names></name> <name><surname>Seyit</surname> <given-names>B</given-names></name> <name><surname>Yuksel</surname> <given-names>K</given-names></name> <name><surname>Cevdet</surname> <given-names>Z</given-names></name> <name><surname>Deniz</surname> <given-names>A</given-names></name></person-group>. <article-title>Mean platelet volume in brucellosis: correlation between brucella standard serum agglutination test results, platelet count, and C-reactive protein</article-title>. <source>Afr Health Sci.</source> (<year>2014</year>) <volume>14</volume>:<fpage>797</fpage>&#x02013;<lpage>801</lpage>. <pub-id pub-id-type="doi">10.4314/ahs.v14i4.4</pub-id><pub-id pub-id-type="pmid">25834485</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okan</surname> <given-names>DH</given-names></name> <name><surname>G&#x000F6;kmen</surname> <given-names>Z</given-names></name> <name><surname>Seyit</surname> <given-names>B</given-names></name> <name><surname>Yuksel</surname> <given-names>K</given-names></name> <name><surname>Cevdet</surname> <given-names>Z</given-names></name> <name><surname>Deniz</surname> <given-names>A</given-names></name></person-group>. <article-title>Brucella endocarditis: clinical, diagnostic, and therapeutic approach</article-title>. <source>Eur J Clin Microbiol Infect Dis.</source> (<year>2003</year>) <volume>22</volume>:<fpage>647</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1007/s10096-003-1026-z</pub-id><pub-id pub-id-type="pmid">14566576</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abid</surname> <given-names>L</given-names></name> <name><surname>Frikha</surname> <given-names>Z</given-names></name> <name><surname>Kallel</surname> <given-names>S</given-names></name> <name><surname>Chokri</surname> <given-names>Z</given-names></name> <name><surname>Ismahen</surname> <given-names>B</given-names></name> <name><surname>Amin</surname> <given-names>B</given-names></name> <etal/></person-group>. <article-title>Brucella myocarditis: a rare and life-threatening cardiac complication of brucellosis</article-title>. <source>Intern Med.</source> (<year>2012</year>) <volume>51</volume>:<fpage>901</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.2169/internalmedicine.51.6379</pub-id><pub-id pub-id-type="pmid">22504247</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>L</given-names></name> <name><surname>Zhou</surname> <given-names>BT</given-names></name> <name><surname>Wang</surname> <given-names>HL</given-names></name> <name><surname>Dou</surname> <given-names>HT</given-names></name> <name><surname>Li</surname> <given-names>TS</given-names></name></person-group>. <article-title>A clinical analysis of six patients with Brucella endocarditis and literature review</article-title>. <source>Zhonghua Nei Ke Za Zhi</source>. (<year>2017</year>) <volume>56</volume>:<fpage>734</fpage>&#x02013;<lpage>7</lpage>. <publisher-loc>Chinese</publisher-loc>.<pub-id pub-id-type="pmid">29036953</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>&#x000C7;etin</surname> <given-names>M</given-names></name> <name><surname>Turfan</surname> <given-names>N</given-names></name> <name><surname>Karaman</surname> <given-names>K</given-names></name> <name><surname>Ya&#x0015F;ar</surname> <given-names>AS</given-names></name> <name><surname>G&#x000FC;ven</surname> <given-names>B</given-names></name> <name><surname>Tun&#x000E7;demir</surname> <given-names>P</given-names></name></person-group>. <article-title>The Pattern of Tpeak-Tend Interval and QTdis, and Pdis in Children with Brucellosis</article-title>. <source>J Trop Pediatr.</source> (<year>2019</year>) <volume>65</volume>:<fpage>474</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1093/tropej/fmy078</pub-id><pub-id pub-id-type="pmid">30624756</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshizane</surname> <given-names>T</given-names></name> <name><surname>Ishihara</surname> <given-names>A</given-names></name> <name><surname>Mori</surname> <given-names>T</given-names></name> <name><surname>Tsuzuku</surname> <given-names>A</given-names></name> <name><surname>Suzuki</surname> <given-names>J</given-names></name> <name><surname>Noda</surname> <given-names>T</given-names></name></person-group>. <article-title>Relative bradycardia in patients with moderate-to-severe COVID-19: a retrospective cohort study</article-title>. <source>SN Compr Clin Med.</source> (<year>2022</year>) <volume>4</volume>:<fpage>65</fpage>. <pub-id pub-id-type="doi">10.1007/s42399-022-01146-9</pub-id><pub-id pub-id-type="pmid">35252761</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiraiwa</surname> <given-names>H</given-names></name> <name><surname>Goto</surname> <given-names>Y</given-names></name> <name><surname>Nakamura</surname> <given-names>G</given-names></name> <name><surname>Yasuda</surname> <given-names>Y</given-names></name> <name><surname>Sakai</surname> <given-names>Y</given-names></name> <name><surname>Kasugai</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Relative bradycardia as a clinical feature in patients with coronavirus disease 2019 (COVID-19): A report of two cases</article-title>. <source>J Cardiol Cases.</source> (<year>2020</year>) <volume>22</volume>:<fpage>260</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.jccase.2020.07.015</pub-id><pub-id pub-id-type="pmid">32837666</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>F</given-names></name> <name><surname>Winchester</surname> <given-names>D</given-names></name> <name><surname>Stalvey</surname> <given-names>C</given-names></name> <name><surname>Jansen</surname> <given-names>M</given-names></name> <name><surname>Lee</surname> <given-names>A</given-names></name> <name><surname>Khuddus</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Proposed mechanisms of relative bradycardia</article-title>. <source>Med Hypotheses.</source> (<year>2018</year>) <volume>119</volume>:<fpage>63</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2018.07.014</pub-id><pub-id pub-id-type="pmid">30122494</pub-id></citation></ref>
</ref-list> 
</back>
</article> 